Adult-onset Still's disease epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(7 intermediate revisions by the same user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Adult-onset Still’s disease}}
{{Adult-onset Still’s disease}}
 
{{CMG}}; {{AE}} {{HK}}
{{CMG}}; {{AE}}


==Overview==
==Overview==
There is a dearth of data regarding the [[incidence]] and [[prevalence]] of adult-onset Still's disease (AOSD). In the Japanese and the European populations, the reported [[prevalence]] rates range from 10 to 340 cases per 100,000 individuals. The disease occurs worldwide and usually affects young adults (age 16-35 years). Adult-onset Still's disease (AOSD) affects females more than males. Aging adults affected by adult-onset Still's disease (AOSD) have a higher rate of development of complications related to AOSD and a higher [[mortality rate]] compared to younger individuals.


==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Incidence and prevalence===
===Incidence and prevalence===
* There is a dearth of data regarding the incidence and prevalence of adult-onset Still's disease (AOSD).
* There is a dearth of data regarding the [[incidence]] and [[prevalence]] of adult-onset Still's disease (AOSD).
*  
* In the Japanese and the European populations, the reported [[prevalence]] rates range from 10 to 340 cases per 100,000 individuals.<ref name="urlAdult-onset Stills disease - ScienceDirect">{{cite web |url=https://www.sciencedirect.com/science/article/pii/S1568997214000986#bb0050 |title=Adult-onset Still's disease - ScienceDirect |format= |work= |accessdate=}}</ref>
* In France, the annual incidence of ASD was estimated to be 0.16 per 100,000 individuals.<ref name="pmid7668903">{{cite journal |vauthors=Magadur-Joly G, Billaud E, Barrier JH, Pennec YL, Masson C, Renou P, Prost A |title=Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France |journal=Ann. Rheum. Dis. |volume=54 |issue=7 |pages=587–90 |date=July 1995 |pmid=7668903 |pmc=1009940 |doi= |url=}}</ref>
* The disease occurs worldwide and usually affects young adults (age 16-35 years).
* In France, the annual [[incidence]] of AOSD was estimated to be 0.16 per 100,000 individuals.<ref name="pmid7668903">{{cite journal |vauthors=Magadur-Joly G, Billaud E, Barrier JH, Pennec YL, Masson C, Renou P, Prost A |title=Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France |journal=Ann. Rheum. Dis. |volume=54 |issue=7 |pages=587–90 |date=July 1995 |pmid=7668903 |pmc=1009940 |doi= |url=}}</ref>
* In Japan, the annual [[incidence]] of AOSD was estimated to be 0.22 per 100,000 individuals.<ref name="pmid9465547">{{cite journal |vauthors=Wakai K, Ohta A, Tamakoshi A, Ohno Y, Kawamura T, Aoki R, Kojima M, Lin Y, Hashimoto S, Inaba Y, Minowa M, Aizawa S, Ichikawa Y, Miyasaka N |title=Estimated prevalence and incidence of adult Still's disease: findings by a nationwide epidemiological survey in Japan |journal=J Epidemiol |volume=7 |issue=4 |pages=221–5 |date=December 1997 |pmid=9465547 |doi= |url=}}</ref>
* In Norway, the annual [[incidence]] of AOSD was estimated to be 0.4 per 100,000 individuals.<ref name="pmid16467042">{{cite journal |vauthors=Evensen KJ, Nossent HC |title=Epidemiology and outcome of adult-onset Still's disease in Northern Norway |journal=Scand. J. Rheumatol. |volume=35 |issue=1 |pages=48–51 |date=2006 |pmid=16467042 |doi=10.1080/03009740510026616 |url=}}</ref>


===Age===
===Age===
* Aging adults affected by adult-onset Still's disease (AOSD) have a higher rate of development of complications related to AOSD and a higher mortality rate compared to younger individuals.<ref name="urlEpidemiology of Hospitalized Adult Onset Stills Disease in United States - ACR Meeting Abstracts">{{cite web |url=http://acrabstracts.org/abstract/epidemiology-of-hospitalized-adult-onset-stills-disease-in-united-states/+ |title=Epidemiology of Hospitalized Adult Onset Still's Disease in United States - ACR Meeting Abstracts |format= |work= |accessdate=}}</ref>
* Aging adults affected by adult-onset Still's disease (AOSD) have a higher rate of development of complications related to AOSD and a higher [[mortality rate]] compared to younger individuals.<ref name="urlEpidemiology of Hospitalized Adult Onset Stills Disease in United States - ACR Meeting Abstracts">{{cite web |url=http://acrabstracts.org/abstract/epidemiology-of-hospitalized-adult-onset-stills-disease-in-united-states/+ |title=Epidemiology of Hospitalized Adult Onset Still's Disease in United States - ACR Meeting Abstracts |format= |work= |accessdate=}}</ref>


=== Gender ===
=== Gender ===
* Adult-onset Still's disease (AOSD) affects females more than females.<ref name="urlEpidemiology of Hospitalized Adult Onset Stills Disease in United States - ACR Meeting Abstracts2">{{cite web |url=http://acrabstracts.org/abstract/epidemiology-of-hospitalized-adult-onset-stills-disease-in-united-states/+ |title=Epidemiology of Hospitalized Adult Onset Still's Disease in United States - ACR Meeting Abstracts |format= |work= |accessdate=}}</ref>
* Adult-onset Still's disease (AOSD) affects females more than males.<ref name="urlEpidemiology of Hospitalized Adult Onset Stills Disease in United States - ACR Meeting Abstracts2">{{cite web |url=http://acrabstracts.org/abstract/epidemiology-of-hospitalized-adult-onset-stills-disease-in-united-states/+ |title=Epidemiology of Hospitalized Adult Onset Still's Disease in United States - ACR Meeting Abstracts |format= |work= |accessdate=}}</ref><ref name="urlA controlled study of the long-term prognosis of adult stills disease - ScienceDirect">{{cite web |url=https://www.sciencedirect.com/science/article/pii/S0002934399803180 |title=A controlled study of the long-term prognosis of adult still's disease - ScienceDirect |format= |work= |accessdate=}}</ref>


=== Race ===
=== Race ===
* Adult-onset Still's disease (AOSD) affects Caucasians more than other races.<ref name="urlEpidemiology of Hospitalized Adult Onset Stills Disease in United States - ACR Meeting Abstracts3">{{cite web |url=http://acrabstracts.org/abstract/epidemiology-of-hospitalized-adult-onset-stills-disease-in-united-states/+ |title=Epidemiology of Hospitalized Adult Onset Still's Disease in United States - ACR Meeting Abstracts |format= |work= |accessdate=}}</ref>
* Adult-onset Still's disease (AOSD) affects Caucasians more than other races.<ref name="urlEpidemiology of Hospitalized Adult Onset Stills Disease in United States - ACR Meeting Abstracts3">{{cite web |url=http://acrabstracts.org/abstract/epidemiology-of-hospitalized-adult-onset-stills-disease-in-united-states/+ |title=Epidemiology of Hospitalized Adult Onset Still's Disease in United States - ACR Meeting Abstracts |format= |work= |accessdate=}}</ref>
===Geographic distribution===


==References==
==References==
Line 27: Line 28:
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category:Rheumatology]]

Latest revision as of 13:22, 23 April 2018

Adult-onset Still's disease

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Adult-onset Still’s Disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Template:Adult-onset Still's disease On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Template:Adult-onset Still's disease

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Adult-onset Still's disease epidemiology and demographics

CDC on Template:Adult-onset Still's disease

Template:Adult-onset Still's disease in the news

Blogs on Template:Adult-onset Still's disease

Risk calculators and risk factors for Template:Adult-onset Still's disease

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Syed Hassan A. Kazmi BSc, MD [2]

Overview

There is a dearth of data regarding the incidence and prevalence of adult-onset Still's disease (AOSD). In the Japanese and the European populations, the reported prevalence rates range from 10 to 340 cases per 100,000 individuals. The disease occurs worldwide and usually affects young adults (age 16-35 years). Adult-onset Still's disease (AOSD) affects females more than males. Aging adults affected by adult-onset Still's disease (AOSD) have a higher rate of development of complications related to AOSD and a higher mortality rate compared to younger individuals.

Epidemiology and Demographics

Incidence and prevalence

  • There is a dearth of data regarding the incidence and prevalence of adult-onset Still's disease (AOSD).
  • In the Japanese and the European populations, the reported prevalence rates range from 10 to 340 cases per 100,000 individuals.[1]
  • The disease occurs worldwide and usually affects young adults (age 16-35 years).
  • In France, the annual incidence of AOSD was estimated to be 0.16 per 100,000 individuals.[2]
  • In Japan, the annual incidence of AOSD was estimated to be 0.22 per 100,000 individuals.[3]
  • In Norway, the annual incidence of AOSD was estimated to be 0.4 per 100,000 individuals.[4]

Age

  • Aging adults affected by adult-onset Still's disease (AOSD) have a higher rate of development of complications related to AOSD and a higher mortality rate compared to younger individuals.[5]

Gender

  • Adult-onset Still's disease (AOSD) affects females more than males.[6][7]

Race

  • Adult-onset Still's disease (AOSD) affects Caucasians more than other races.[8]

References

  1. "Adult-onset Still's disease - ScienceDirect".
  2. Magadur-Joly G, Billaud E, Barrier JH, Pennec YL, Masson C, Renou P, Prost A (July 1995). "Epidemiology of adult Still's disease: estimate of the incidence by a retrospective study in west France". Ann. Rheum. Dis. 54 (7): 587–90. PMC 1009940. PMID 7668903.
  3. Wakai K, Ohta A, Tamakoshi A, Ohno Y, Kawamura T, Aoki R, Kojima M, Lin Y, Hashimoto S, Inaba Y, Minowa M, Aizawa S, Ichikawa Y, Miyasaka N (December 1997). "Estimated prevalence and incidence of adult Still's disease: findings by a nationwide epidemiological survey in Japan". J Epidemiol. 7 (4): 221–5. PMID 9465547.
  4. Evensen KJ, Nossent HC (2006). "Epidemiology and outcome of adult-onset Still's disease in Northern Norway". Scand. J. Rheumatol. 35 (1): 48–51. doi:10.1080/03009740510026616. PMID 16467042.
  5. "Epidemiology of Hospitalized Adult Onset Still's Disease in United States - ACR Meeting Abstracts".
  6. "Epidemiology of Hospitalized Adult Onset Still's Disease in United States - ACR Meeting Abstracts".
  7. "A controlled study of the long-term prognosis of adult still's disease - ScienceDirect".
  8. "Epidemiology of Hospitalized Adult Onset Still's Disease in United States - ACR Meeting Abstracts".

Template:WH Template:WS